comparemela.com

Latest Breaking News On - Soundbite medical solutions - Page 2 : comparemela.com

Soundbite Medical Solutions Inc : Soundbite Medical s Proprietary Shock Wave Technology Now Cracks Calcium In Germany, a Promising Solution for CLI Patients

Soundbite Medical Solutions Inc : Soundbite Medical s Proprietary Shock Wave Technology Now Cracks Calcium In Germany, a Promising Solution for CLI Patients
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Soundbite Medical Solutions Announces FDA Approval for SoundBite® Crossing System

Press release content from Business Wire. The AP news staff was not involved in its creation. Soundbite Medical Solutions Announces FDA Approval for SoundBite® Crossing System - Peripheral (14P) April 22, 2021 GMT MONTREAL (BUSINESS WIRE) Apr 22, 2021 Soundbite announces FDA 510(k) Approval for SoundBite ® Crossing System - Peripheral (SCS-P) with the 0.014” Active Wire (14P). The SoundBite® Crossing System – Peripheral (14P) is a recanalization tool, designed to help physician’s placement of conventional guidewires or treatment devices in the intraluminal space beyond chronic total occlusions (CTOs) in patients suffering from heavily calcified above-the-knee (ATK) and below-the-knee (BTK) peripheral artery disease (PAD). “This approval is an important step in furthering our mission of making a positive impact on the lives of patients with critical limb ischemia (CLI) and challenging calcified BTK disease. We believe that this approval is very relevant as it represe

Peripheral CTO Device Market to Register Exponential Growth During 2020 – 2027 | Key Players – Boston Scientific Corporation, Avinger, Inc , Cardinal Health – KSU

Come and apply the insights recommended by the honchos of the Peripheral CTO Device industry.   Peripheral CTO Device Market Report, published by Decisive Markets Insights, provides granular information & analysis on the size, share, growth patterns, segment and forecast of the market from, 2020 – 2027.The report covers the rapidly evolving market scenario and the current and future evaluation of their impact on the overall industry along with regional coverage across the globe. With an in-depth report on sales growth and profitability, it also covers the accurate trend and analysis that would impact the market in the coming years. The analysis provides key players, a competitive perspective so as to formulate their business strategies accordingly.

SoundBite Medical Solutions Announces First Use of its Novel 0 014 Active Wire to Successfully Treat Calcified Below-The-Knee CTOs

News Category Global Banking & Finance Reviews SoundBite Medical Solutions Announces First Use of its Novel 0.014” Active Wire to Successfully Treat Calcified Below-The-Knee CTOs SoundBite Medical Solutions Announces First Use of its Novel 0.014” Active Wire to Successfully Treat Calcified Below-The-Knee CTOs SoundBite Medical Solutions Inc. (SBMS) announced today the first use of its novel Active Wire 0.014 platform in the successful treatment of patients suffering from critical limb ischemia (CLI) with heavily calcified below-the-knee (BTK) chronic total occlusions (CTO). The procedures were performed by Professor Marianne Brodmann, Head of the Clinical Division of Angiology, Department of Internal Medicine, and PD Dr Rief at the Medical University of Graz, Austria. Vascular calcium poses a major challenge for the endovascular treatment of lesions. Our early experience with the 0.014 platform of the SoundBite

SoundBite Medical Solutions Announces First Use of its Novel 0 014 Active Wire to Successfully Treat Calcified Below-The-Knee CTOs

Press release content from Business Wire. The AP news staff was not involved in its creation. SoundBite Medical Solutions Announces First Use of its Novel 0.014” Active Wire to Successfully Treat Calcified Below-The-Knee CTOs January 26, 2021 GMT MONTREAL (BUSINESS WIRE) Jan 26, 2021 SoundBite Medical Solutions Inc. (SBMS) announced today the first use of its novel Active Wire 0.014” platform in the successful treatment of patients suffering from critical limb ischemia (CLI) with heavily calcified below-the-knee (BTK) chronic total occlusions (CTO). The procedures were performed by Professor Marianne Brodmann, Head of the Clinical Division of Angiology, Department of Internal Medicine, and PD Dr Rief at the Medical University of Graz, Austria. “Vascular calcium poses a major challenge for the endovascular treatment of lesions. Our early experience with the 0.014” platform of the SoundBite ® Crossing System in 5 patients with calcific BTK CTOs shows impressive crossing

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.